Insulin Resistance in Apparently Healthy Adult Nigerians: Association with Magnesium Status
Fasting plasma levels of magnesium, glucose and insulin were determined in 120 apparently healthy adults. Insulin resistance was calculated as HOMA-IR. Prevalence of insulin resistance was estimated and the association between plasma magnesium levels and HOMA-IR was determined.
About 19.2% of the study subjects were classified as having insulin resistance. Prevalence was higher among males compared to females (21.0% vs. 17.0%) and among obese compared to normal weight subjects (26.1% vs. 14.9%). Subjects with hypomagnesemia had higher prevalence of insulin resistance compared with subjects who had normal plasma magnesium levels (50.0% vs. 14.4%). Insulin resistance was inversely associated with plasma magnesium level independent of age, gender and BMI.
Insulin resistance is relatively common among apparently healthy individuals in this study. Magnesium deficiency was found to be a significant predictor of insulin resistance. We recommend further studies that will investigate whether optimization of magnesium status in general population or among individuals at risk of developing type 2 diabetes will be a useful approach in lowering insulin resistance and prevent or delay onset of type 2 diabetes mellitus in our setting.
Bermudez V, Salazar J, Martínez MS, Chávez-Castillo M, Olivar LC, Calvo MJ, et al. (2016) Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela. Adv Prev Med. 2016: 9405105.
Cahill F, Shahidi M, Shea J, Wadden D, Gulliver W, Randell E, et al. (2013) High Dietary Magnesium Intake Is Associated with Low Insulin Resistance in the Newfoundland Population. PLoS ONE. 8(3): e58278.
Costello RB, Elin RJ, Rosanoff A, Guerrero-Romero F, Hruby A, Lutsey PL, et al. (2016) Perspective: the case for an evidence-based reference interval for serum magnesium: The time has come. Adv Nutr. 7(6):977-993.
Do HD, Lohsoonthorn V, Jiamjarasrangsi W, Lertmaharit S, Williams MA. (2010) Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old. Diabetes Res Clin Pract. 89(3): 303-308.
Friedrich N, Thuesen B, Jørgensen T, Juul A, Spielhagen C, Wallaschofksi H, et al. (2012) The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care. 35(4):768-773.
Gommers LMM, Hoenderop JGJ, Bindels RJM, De Baaij JHF. (2016) Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 65(1):3-13
Guerrero-Romero F, Rodríguez-Morán M. (2006) Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev. 22: 471-476.
Guerrero-Romero F, Rodríguez-Morán M. (2013) Serum Mg in the metabolically obese normal-weight and healthy-obese subjects. Eur J Intern Med. 24: 639-643.
Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH, et al. (2004) Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. Double-blind placebo-controlled randomized trial. Diabetes Metab. 30(3): 253-258
Huerta MG, Roemmich JN, Kington ML, Bobvjerg VE, Weltman AL, Holmes VF, et al. (2005) Magnesium Deficiency Is Associated With Insulin Resistance in Obese Children. Diabetes Care. 28:1175-1181.
Huguette YMF, Boris AKG, Raïssa NF, Laure NJ, Julius O. (2010) Prevalence of insulin resistance in obese Cameroonian women. Journal of Diabetes and Endocrinology. 1(2): 19-26.
Humphries S, Kushner H, Falkner B. (1999) Low dietary magnesium is associated with insulin resistance in a sample of young, non diabetic Black Americans. Am J Hypertens. 12: 747-756.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL: (1999) Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 159(18):2151-2159
Larsson SC, Wolk A. (2007) Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 262(2): 208-214
Lebovitz HE. (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 109 (Suppl 2):S135-S148
Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, et al. (2004) Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 27: 134-140.
Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. (1993) Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 21:1024-1029.
Oli JM, Adeyemo AA, Okafor GO, Ofoegbu EN, Onyenekwe B, Chukwuka CJ, et al. (2009) Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus. Metab Syndr Relat Disord. 7: 595‑599.
Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, et al. (1992) Daily magnesium supplement improves glucose handling in elderly subjects. Am J Clin Nutr. 55(6):1161-1167
Paul SJ. (2009) Metabolic consequences of hyperglycemia and insulin resistance. Insulin. 4(1): 2-14
Resnick LM, Gupta RK, Gruenspan H, Alderman MH, Laragh JH: (1990) Hypertension and peripheral insulin resistance: possible mediating role of intracellular free magnesium. Am J Hypertens. 3:373-379.
Rosolova H, Mayer O Jr, Reaven GM: (2000) Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism. 49:418-420.
Swaminathan R. (2003) Magnesium Metabolism and its Disorders. Clin Biochem Rev. 24: 47-66
Wallace TM, Levy JC, Mathews DR. (2004) Use and abuse of HOMA modelling. Diabetes Care. 27:1487-1495.
Young EE, Okafor CN, Iroezindu MO, Agbalu IS. (2016) Insulin resistance, metabolic